Project organization: University of Delaware

Modernizing clearance and quantification of host-cell proteins in mAb manufacture

Optimizing Next Generation Sequencing for Sensitive Detection of Viral Adventitious Agents in Biologics

Recombinant Antigen Vectors

Cell Culture Glycosylation Multi-Scale Mechanistic Modeling (Phase 1)

Measuring Glycans from Biopharmaceuticals Using LC-Q/TOF

Center of Excellence in Host-Cell Protein Analysis

Evaluation of Next Generation Sequencing (NGS) as a Rapid, Alternative Assay for In Vivo and In Vitro Adventitious Virus Testing for Vaccine Safety

Cell Separation, Processing, and Expansion for Cell Therapy Applications

Innovative Scalable Technologies for Production of Cell Therapies

Establishing Testbeds for Biopharmaceutical Manufacturing Workforce Development in Louisiana, North Carolina, Maryland, Delaware, and Texas

Affinity Precipitation Purification of Virus-Like Particles

Mechanistic Modeling for Enhanced Chromatographic Productivity